Annual Operating Expenses
$275.94 M
+$67.81 M+32.58%
December 31, 2024
Summary
- As of March 13, 2025, COGT annual total operating expenses is $275.94 million, with the most recent change of +$67.81 million (+32.58%) on December 31, 2024.
- During the last 3 years, COGT annual operating expenses has risen by +$200.39 million (+265.24%).
- COGT annual operating expenses is now at all-time high.
Performance
COGT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$73.73 M
-$1.68 M-2.23%
December 31, 2024
Summary
- As of March 13, 2025, COGT quarterly total operating expenses is $73.73 million, with the most recent change of -$1.68 million (-2.23%) on December 31, 2024.
- Over the past year, COGT quarterly operating expenses has dropped by -$1.68 million (-2.23%).
- COGT quarterly operating expenses is now -2.23% below its all-time high of $75.41 million, reached on September 30, 2024.
Performance
COGT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
COGT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.6% | -2.2% |
| 3 y3 years | +265.2% | -2.2% |
| 5 y5 years | +404.7% | +829.7% |
COGT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +265.2% | -2.2% | +187.6% |
| 5 y | 5-year | at high | +539.3% | -2.2% | +829.7% |
| alltime | all time | at high | +2781.0% | -2.2% | +833.8% |
Cogent Biosciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $275.94 M(+32.6%) | $73.73 M(-2.2%) |
| Sep 2024 | - | $75.41 M(+17.1%) |
| Jun 2024 | - | $64.39 M(+3.2%) |
| Mar 2024 | - | $62.40 M(+7.2%) |
| Dec 2023 | $208.13 M(+40.8%) | $58.23 M(-2.3%) |
| Sep 2023 | - | $59.58 M(+26.5%) |
| Jun 2023 | - | $47.09 M(+8.9%) |
| Mar 2023 | - | $43.24 M(-1.2%) |
| Dec 2022 | $147.84 M(+95.7%) | $43.74 M(+18.8%) |
| Sep 2022 | - | $36.82 M(+2.7%) |
| Jun 2022 | - | $35.85 M(+14.1%) |
| Mar 2022 | - | $31.42 M(+22.5%) |
| Dec 2021 | $75.55 M(+75.0%) | $25.64 M(+29.4%) |
| Sep 2021 | - | $19.82 M(+14.6%) |
| Jun 2021 | - | $17.29 M(+35.1%) |
| Mar 2021 | - | $12.80 M(+11.7%) |
| Dec 2020 | $43.16 M | $11.46 M(+8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $10.60 M(+33.7%) |
| Jun 2020 | - | $7.93 M(-39.8%) |
| Mar 2020 | - | $13.17 M(+1.0%) |
| Dec 2019 | $54.68 M(+19.5%) | $13.05 M(-0.1%) |
| Sep 2019 | - | $13.06 M(-4.6%) |
| Jun 2019 | - | $13.68 M(-8.2%) |
| Mar 2019 | - | $14.89 M(+16.3%) |
| Dec 2018 | $45.74 M(+32.5%) | $12.81 M(+1.5%) |
| Sep 2018 | - | $12.62 M(+13.6%) |
| Jun 2018 | - | $11.11 M(+20.6%) |
| Mar 2018 | - | $9.21 M(+2.3%) |
| Dec 2017 | $34.51 M(+35.7%) | $9.00 M(-5.2%) |
| Sep 2017 | - | $9.50 M(+17.1%) |
| Jun 2017 | - | $8.11 M(+2.7%) |
| Mar 2017 | - | $7.90 M |
| Dec 2016 | $25.43 M(+165.5%) | - |
| Dec 2015 | $9.58 M | - |
FAQ
- What is Cogent Biosciences annual total operating expenses?
- What is the all time high annual operating expenses for Cogent Biosciences?
- What is Cogent Biosciences annual operating expenses year-on-year change?
- What is Cogent Biosciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cogent Biosciences?
- What is Cogent Biosciences quarterly operating expenses year-on-year change?
What is Cogent Biosciences annual total operating expenses?
The current annual operating expenses of COGT is $275.94 M
What is the all time high annual operating expenses for Cogent Biosciences?
Cogent Biosciences all-time high annual total operating expenses is $275.94 M
What is Cogent Biosciences annual operating expenses year-on-year change?
Over the past year, COGT annual total operating expenses has changed by +$67.81 M (+32.58%)
What is Cogent Biosciences quarterly total operating expenses?
The current quarterly operating expenses of COGT is $73.73 M
What is the all time high quarterly operating expenses for Cogent Biosciences?
Cogent Biosciences all-time high quarterly total operating expenses is $75.41 M
What is Cogent Biosciences quarterly operating expenses year-on-year change?
Over the past year, COGT quarterly total operating expenses has changed by -$1.68 M (-2.23%)